Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Neurophth Therapeutics Conducts Special Interview with Dr. Satoshi Kashii on World Sight Day 2022-10-13 20:30
Menarini Silicon Biosystems's CELLSEARCH® CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination 2022-10-13 20:00
Harbour BioMed Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting 2022-10-13 19:05
Samsung Biologics obtains three global ISO certifications 2022-10-13 19:00
Jacobio Pharma to Collaborate with Merck on Clinical Trial of JAB-21822 in Combination with Cetuximab 2022-10-13 09:00
China Matters' Feature: How is Dongguan's new "super microscope" helping scientists dive deeper? 2022-10-12 23:46
Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants 2022-10-12 21:35
WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody 2022-10-12 09:00
CSafe and BioLife Solutions, Inc. announce partnership to expand supply chain solutions for the cell and gene therapy market 2022-10-11 22:10
Great Bay Bio Announces Official Launch of Site-Specific Integration Platform for Cell Line Development, AlfaCell® 2022-10-11 20:40
HanAll's Licensed Partner in China Enters Sublicense Agreement with CSPC to Further Accelerate Development of Batoclimab 2022-10-11 19:00
Samsung Biologics unlocks additional capacity for production at its newest Plant 4 2022-10-11 19:00
Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib 2022-10-11 13:00
JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in Patients with Relapsed or Refractory Follicular Lymphoma 2022-10-10 20:00
Ascletis Announces Dosing of 24 Healthy Subjects of the First 3 Cohorts in Multiple-Dose Escalation Phase I Clinical Trial of Oral RdRp Inhibitor ASC10 for COVID-19 2022-10-10 08:10
Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW014, an oral small molecule GLP-1 receptor agonist for the Treatment of Obesity and Type 2 Diabetes 2022-10-10 08:00
Antengene Announces Upcoming Presentations at the 2022 Society for Immunotherapy of Cancer Annual Meeting 2022-10-08 10:43
First patient treated in Clarity's therapeutic prostate cancer trial 2022-10-07 21:06
Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions 2022-10-07 17:22
Servier unveils its 2030 ambition and reveals a new visual identity 2022-10-06 13:30
1 111 112 113 114 115 414